Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Dividends

Explore dividend yields, payout ratios, and historical trends to maximize your investment strategies.

Last Close
May 24 04:00PM ET
2.64
Dollar change
+0.08
Percentage change
3.13
%
Index- P/E- EPS (ttm)-3.05 Insider Own7.90% Shs Outstand38.17M Perf Week4.76%
Market Cap101.19M Forward P/E- EPS next Y-2.46 Insider Trans24.32% Shs Float35.30M Perf Month37.50%
Income-116.19M PEG- EPS next Q-0.76 Inst Own56.90% Short Float2.98% Perf Quarter-32.48%
Sales0.00M P/S- EPS this Y5.95% Inst Trans0.84% Short Ratio3.36 Perf Half Y76.00%
Book/sh2.79 P/B0.95 EPS next Y15.30% ROA-63.45% Short Interest1.05M Perf Year-7.04%
Cash/sh3.19 P/C0.83 EPS next 5Y- ROE-73.11% 52W Range1.33 - 4.30 Perf YTD8.64%
Dividend Est.- P/FCF- EPS past 5Y-81.69% ROI-107.72% 52W High-38.58% Beta2.91
Dividend TTM- Quick Ratio5.03 Sales past 5Y0.00% Gross Margin- 52W Low98.50% ATR (14)0.17
Dividend Ex-Date- Current Ratio5.03 EPS Y/Y TTM-12.48% Oper. Margin0.00% RSI (14)60.91 Volatility5.14% 6.95%
Employees67 Debt/Eq0.01 Sales Y/Y TTM- Profit Margin- Recom2.00 Target Price7.28
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q6.31% Payout- Rel Volume0.31 Prev Close2.56
Sales Surprise- EPS Surprise13.63% Sales Q/Q- EarningsMay 15 AMC Avg Volume313.07K Price2.64
SMA2018.28% SMA5013.78% SMA20010.46% Trades Volume97,726 Change3.13%
Date Action Analyst Rating Change Price Target Change
Oct-17-22Upgrade JMP Securities Mkt Perform → Mkt Outperform $20
Jul-07-22Initiated Mizuho Buy $6
Jun-23-22Downgrade Stifel Buy → Hold $36 → $5
Jun-23-22Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jun-23-22Downgrade Jefferies Buy → Hold $32 → $3
May-10-22Initiated BTIG Research Buy $33
Apr-21-22Initiated Berenberg Buy $33
Dec-15-21Initiated Goldman Neutral $16
Oct-13-20Initiated Stifel Buy $36
Oct-13-20Initiated JMP Securities Mkt Outperform $51
May-17-24 05:00PM
May-15-24 10:54PM
04:05PM
May-07-24 09:15AM
May-02-24 07:00AM
07:00AM Loading…
Apr-15-24 07:00AM
Apr-11-24 07:00AM
Apr-03-24 07:00AM
Mar-08-24 07:00AM
Feb-28-24 12:00PM
Feb-22-24 04:05PM
Feb-15-24 02:56PM
Feb-08-24 04:02PM
Jan-08-24 07:00AM
Jan-03-24 07:00AM
07:00AM Loading…
Dec-12-23 07:00AM
Dec-05-23 10:25AM
Nov-29-23 07:00AM
Nov-28-23 07:00AM
Nov-15-23 08:15AM
Nov-09-23 04:05PM
Nov-08-23 07:00AM
Oct-05-23 04:30PM
Sep-28-23 07:00AM
Sep-19-23 07:00AM
Sep-08-23 12:00PM
Aug-31-23 09:35AM
Aug-29-23 09:55AM
Aug-10-23 04:05PM
Jul-17-23 07:00AM
11:52AM Loading…
Jul-06-23 11:52AM
07:00AM
Jun-08-23 06:08AM
Jun-07-23 08:10AM
May-31-23 07:00AM
May-22-23 07:00AM
May-12-23 11:34AM
May-11-23 04:05PM
12:25PM
May-08-23 07:00AM
Apr-29-23 08:45AM
Apr-25-23 04:01PM
Apr-11-23 07:00AM
Apr-02-23 08:14AM
Mar-28-23 12:00PM
01:00AM
Mar-23-23 04:05PM
Mar-08-23 07:00AM
Mar-06-23 07:00AM
Feb-01-23 07:00AM
Jan-31-23 07:00AM
Jan-28-23 08:00AM
Jan-27-23 10:08AM
Jan-17-23 01:00AM
Jan-05-23 07:00AM
Jan-03-23 06:26AM
Dec-21-22 07:00AM
Dec-09-22 05:34AM
Dec-05-22 07:30AM
Dec-01-22 07:00AM
Nov-29-22 11:00AM
Nov-28-22 07:00AM
Nov-21-22 07:00AM
Nov-16-22 07:00AM
Nov-10-22 04:05PM
Nov-09-22 07:00AM
Nov-07-22 07:00AM
Oct-30-22 08:29AM
Oct-17-22 07:00AM
Sep-16-22 08:14AM
Sep-06-22 03:22PM
07:00AM
Aug-20-22 08:01AM
Aug-15-22 04:05PM
Aug-03-22 11:28AM
Aug-02-22 03:30PM
Jul-25-22 07:00AM
Jul-08-22 04:19PM
Jun-22-22 04:49PM
01:29PM
11:31AM
08:25AM
08:21AM
07:00AM
Jun-07-22 07:00AM
May-22-22 10:43AM
May-19-22 12:06PM
May-17-22 05:39AM
May-16-22 04:49PM
07:00AM
May-12-22 04:05PM
May-11-22 04:15PM
May-09-22 07:00AM
May-05-22 12:04PM
08:00AM
May-04-22 06:46PM
Apr-28-22 12:54AM
Apr-26-22 08:00AM
Apr-20-22 09:02AM
Apr-12-22 12:45AM
Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Litton Mark JamesChief Executive OfficerJan 05 '24Sale2.914,82014,026144,397Jan 08 04:40 PM
Worthington MarkGeneral CounselJan 05 '24Sale2.912,4127,01934,452Jan 08 04:38 PM
Lenington RachelChief Operating OfficerJan 05 '24Sale2.912,4127,01913,395Jan 08 04:35 PM
PERCEPTIVE ADVISORS LLCDirectorDec 29 '23Buy2.38163,954390,2115,402,964Dec 29 05:24 PM
PERCEPTIVE ADVISORS LLCDirectorDec 28 '23Buy2.44409,598999,4195,239,010Dec 29 05:24 PM
PERCEPTIVE ADVISORS LLCDirectorDec 27 '23Buy2.2832,13473,2664,829,412Dec 29 05:24 PM
Gengos AndrewSee BelowJun 07 '23Buy3.4315,00051,44580,012Jun 09 05:06 PM
Gengos AndrewSee BelowJun 05 '23Buy3.0045,000135,15065,012Jun 06 07:36 PM
MOEBIUS HANSChief Medical OfficerJun 02 '23Option Exercise1.357,88210,64181,482Jun 06 07:35 PM
Gengos AndrewSee BelowJun 02 '23Buy2.8220,01256,42220,012Jun 06 07:36 PM